Relative Intelligence · Application Software

How Veeva Systems (VEEV) compares with the whole market and its popular alternatives
Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on VEEV alone. It places VEEV (Veeva Systems Inc.) against 19 popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where VEEV stands in the market, and of the alternatives worth a closer look.
Period covered: VEEV's full trading record, from October 2013 through September 2026. The crash tests reach back to 2000 using older funds and the S&P 500. All returns include reinvested dividends. Data as of October 20, 2026.
Data as of October 20, 2026. Full tables and charts read best on a larger screen.
On this page12 sections
Key findings
- Right nowOver the past 6 months, VEEV rose 88.7% against 9.1% for the S&P 500 and 11.2% for the Nasdaq 100. At a glance ↓
- Stock or market?More than an industry move: VEEV rose 61.4% over the past 3 months, against 15.0% for the application software ETF IGV (iShares Expanded Tech-Software Sector ETF). The S&P 500 rose 3.9%. VEEV rose 22.0% last month as the S&P 500 fell 0.6% and the Nasdaq 100 fell 3.2%.
- Past 1 to 3 yearsA ahead of 92% of stocks worth at least $300 million over 10 years, but ahead of 53% of the stocks worth at least $300 million over 3 years. That said, VEEV lagged its application software peers in 2023, then moved up the pack in 2025. Market rank ↓
- Long termVEEV turned $10,000 into $81,500 over the past decade, against $42,100 in the S&P 500. That said, over 5 years VEEV trailed the index: 0.4% against 81.7%. Growth of $10,000 ↓
- In a crashVEEV fell harder than the S&P 500 in three of four sell-offs. The Covid crash was the exception: VEEV fell 26.7%, less than the S&P 500's 33.7%. Crash tests ↓
- DiversificationOver 10 years VEEV kept more of the market's gains than of its losses: in the S&P 500's rising months it gained 1.1 times as much as the index, and in falling months it lost 89% as much, with a beta of 0.87. On the flip side, when the S&P 500 had a down month, VEEV usually fell with it (17 of 22 months). By year ↓
- Better options
- Popular alternatives
- LLY (Eli Lilly and Company), MRK (Merck & Co., Inc.) and SAP earned more than VEEV with less volatility over the past 5 years. LLY returned 40.7% a year at 32.8% volatility, against a loss of 0.1% a year at 39.6%.
- Nearby categories and themes
- MSFT (Microsoft, software) and V (Visa, payment processing) earned more than VEEV with less volatility over the past 5 years. MSFT returned 12.5% a year at 28.2% volatility, against a loss of 0.1% a year at 39.6%.
- Whole market
- 1,735 of the 3,633 stocks and funds worth at least $500 million earned more than VEEV with less volatility over the past 5 years, among them AAPL (Apple), GOOG (Alphabet) and MSFT (Microsoft).
How much would $10,000 in VEEV have grown?
This chart tracks a hypothetical $10,000 investment in VEEV over the past 12 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of VEEV over the same span and VEEV's popular alternatives, among those that traded for the entire period. A second view covers the past 5 years, the period the better options further down the page are judged on. It shows not only where each investment ended up but also how smooth or uneven the path was.
Note: VEEV began trading on October 16, 2013, so the chart cannot reach back to the dot-com bust, the 2008 financial crisis or two other sell-offs. It covers the most recent 12 years of VEEV's record, starting at the end of September 2014.
- $10,000 invested in VEEV at the end of September 2014 would have grown to $101,328 by September 2026, more than the $47,240 it would have become in SPY, an S&P 500 fund.
- Five of the eight other investments on the chart ended ahead of VEEV, and PANW finished highest, at $243,002.
Choose a period
From the end of September 2014 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 145 of the 2,461 stocks and funds worth at least $500 million that traded the whole period ended ahead of VEEV; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- PANW$243,002+2,330% total · +30.5% a year
- LLY$220,143+2,101% total · +29.4% a year
- MPC$133,007+1,230% total · +24.1% a year
- MSFT$131,479+1,215% total · +23.9% a year
- NOW$113,946+1,039% total · +22.5% a year
- VEEV$101,328+913% total · +21.3% a year
- CRL$49,381+394% total · +14.2% a year
- SPY (S&P 500)$47,240+372% total · +13.8% a year
- SAP$34,730+247% total · +10.9% a year
- HSTM$13,105+31.1% total · +2.3% a year
From the end of September 2021 to the end of September 2026. Hover over a fund in the key to pick out its line. 2,542 of the 3,628 stocks and funds worth at least $500 million that traded the whole period ended ahead of VEEV; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- LLY$52,411+424% total · +39.3% a year
- MEDP$32,977+230% total · +27.0% a year
- MRK$22,538+125% total · +17.6% a year
- SPY (S&P 500)$19,000+90.0% total · +13.7% a year
- SAP$16,715+67.2% total · +10.8% a year
- TMO$11,986+19.9% total · +3.7% a year
- IQV$11,224+12.2% total · +2.3% a year
- NOW$10,768+7.7% total · +1.5% a year
- VEEV$9,905−0.9% total · −0.2% a year
- CRL$7,149−28.5% total · −6.5% a year
VEEV at a glance
This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout. These figures serve as the baseline for every comparison that follows.
Note: VEEV began trading on October 16, 2013, so every figure here, including its worst decline, covers only the time since then. None of them reflect the dot-com bust, the 2008 financial crisis or two other sell-offs.
- VEEV's deepest decline since it began trading in 2013 was 61.4%, from October 2013 to May 2014. It took about two years from the low to climb back to its old high.
- Over 12 full calendar years, VEEV's best was 2020, when it returned 93.5%, and its worst was 2022, when it lost 36.8%. It lost money in three of those years.
- VEEV is 6.6% below its all-time high.
The company
- Market value
- $52B
- Industry
- Software - Application
- Price history from
- October 2013
Returns
- Past 1 year
- +11.5%total return
- Past 3 years
- +59.0%+16.7% a year
- Past 5 years
- −0.4%−0.1% a year
- Past 10 years
- +715%+23.3% a year
- Best calendar year
- +93.5%2020
- Worst calendar year
- −36.8%2022
- Losing years
- 3 of 12full calendar years
Risk
- Volatility
- 39.6%typical yearly swing, 5 years
- Sharpe ratio
- 0.19return per unit of risk, 5 years
- Worst decline ever
- −61.4%Oct 2013 to May 2014
- From its all-time high
- −6.6%below the peak
VEEV against the whole market
Where VEEV ranks among every stock and fund, and what across the market has done better.
How does VEEV rank among all stocks?
This section ranks VEEV on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history. Where the comparisons with its popular alternatives show how VEEV stacks up against its peers, these rankings show where it stands in the market as a whole.
- VEEV's 10-year return ranks in the top 8% of the 2,202 stocks worth at least $300 million with 10 years of history.
Ranked against U.S.-listed stocks worth at least $300M that have enough history for each measure, so the count changes from row to row; smaller stocks are left out. Lower volatility and smaller declines rank higher.
| Measure | VEEV | Rank | Standing |
|---|---|---|---|
| 1-year return | +11.5% | 1,529 of 3,287 | top 47% |
| 3-year return | +59.0% | 1,414 of 3,017 | top 47% |
| 5-year return | −0.4% | 1,738 of 2,893 | bottom 41% |
| 10-year return | +715% | 185 of 2,202 | top 8% |
| Volatility, 5 years | 39.6% | 1,438 of 2,893 | top 50% |
| Sharpe ratio, 5 years | 0.19 | 1,857 of 2,893 | bottom 37% |
| Worst decline, past 10 years | −55.7% | 701 of 2,187 | top 32% |
What has beaten VEEV on both return and risk?
Each dot is an investment, placed by how much it earned a year over the past 5 years (higher is better) and how much its price swung, its volatility (further left is calmer). VEEV sits where the dashed lines cross. Anything in the green box above and to the left earned more than VEEV with smaller swings, a better trade-off over this period on both counts. Past results are no promise, but a name in the box is worth a closer look.
- 901 stocks and 834 ETFs worth at least $500 million sit in the green region: each earned more than VEEV over the past 5 years with smaller price swings. That is 48% of the 3,633 screened.
- Among those with at least half VEEV's swings, CAH has the best return for its risk: 42.1% a year at 24.7% volatility, 37% less than VEEV's 39.6%, and a Sharpe ratio (return above cash per unit of volatility) of 1.55 against 0.19 for VEEV. PBR-A earned the most, 51.8% a year, while still swinging less than VEEV (37.5% against 39.6%).
- Among VEEV's popular alternatives, LLY, MRK and SAP are in the region. LLY earned 40.7% a year against a loss of 0.1% a year for VEEV, at 32.8% volatility, 17% less than VEEV's 39.6%.
Annual return is the annualized total return with dividends reinvested, and volatility the annualized swing in daily prices, both over 5 years. Labeled dots are the strongest picks from the table below and the names called out above, colored by how close they sit to VEEV; faint dots are 92 more of the 1,735 in the green region (the strongest, one per fund family). 3,633 stocks and funds worth at least $500 million were screened. Hover over a dot for its figures.
- Popular alternatives
- Same and neighboring categories, and shared themes
- The whole market
- Others in the green region
Is there a better investment than VEEV?
Investments that beat VEEV over the past 5 years on return, volatility, drawdowns, consistency, crash losses or fees, from its popular alternatives out to the whole market.
- Among VEEV's popular alternatives, LLY, MRK and SAP earned more than VEEV with less volatility over the past 5 years. LLY returned 40.7% a year at 32.8% volatility, against a loss of 0.1% a year at 39.6%.
- Looking beyond its popular alternatives, MSFT (software) and V (payment processing) earned more than VEEV with less volatility over the past 5 years. MSFT returned 12.5% a year at 28.2% volatility, against a loss of 0.1% a year at 39.6%.
- Across the whole market, 1,735 of the 3,633 stocks and funds worth at least $500 million earned more than VEEV with less volatility over the past 5 years, among them AAPL, GOOG and MSFT.
How this works
The table below lists investments that beat VEEV over the past 5 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes. It checks VEEV's popular alternatives first, then the rest of its own and neighboring categories, then every stock and fund worth at least $500 million, and shows the strongest few in each group. The full list of those with a higher return and lower volatility than VEEV follows the table.
Annual return is the annualized total return with dividends reinvested. Annual return, volatility and the Sharpe ratio cover 5 years; the worst decline covers the past 10 years. Green marks a better figure than VEEV's. "On the frontier" means no other option shown or tested earned more with less volatility. Funds that hold the same thing are shown once. Beyond the popular alternatives, nothing with more than 1.5× VEEV's volatility counts as better.
These figures cover the past 5 years. Green marks a better figure than VEEV's.
| Investment | Why it is better | Past 5 years | Downside | Long run | Fit | ||||
|---|---|---|---|---|---|---|---|---|---|
| Annual return?higher is better | Volatility?lower is calmer | Sharpe?return per unit of risk | Worst decline?past 10 years | 10Y returntotal | Corr. with VEEV?lower diversifies more | Expenseper year | |||
| −0.1% | 39.6% | 0.19 | −55.7% | +715% | 1.00 | — | |||
| +12.7% | 17.1% | 0.79 | −33.7% | +321% | 0.38 | 0.09% | |||
| Popular alternativesbest 6 shownThe investments people most often weigh against VEEV. 7 of 17 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes | +40.7% | 32.8% | 1.21 | −34.5% | +1,807% | -0.01 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +16.3% | 24.8% | 0.74 | −43.4% | +241% | 0.13 | — | ||
| Higher return, lower volatility | +11.5% | 30.0% | 0.52 | −52.5% | +205% | 0.51 | — | ||
| Higher return, lower volatility | +2.9% | 27.8% | 0.24 | −40.9% | +366% | 0.33 | — | ||
| Higher return, lower volatility | +1.3% | 34.7% | 0.21 | −51.5% | +260% | 0.40 | — | ||
HSTMHealthStream, Inc. · Medical - Healthcare Information Services | Higher return, lower volatility | +3.9% | 29.4% | 0.28 | −42.7% | +32.0% | 0.23 | — | |
| Same and neighboring categories, and shared themesbest 6 shownEverything else in Application Software and Software and the categories next to it (Enterprise Software, Payment Processing, Semiconductors), plus VEEV's specific themes. 39 of 129 passed at least one test. | |||||||||
| Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +31.9% | 43.4% | 0.86 | −48.0% | +1,274% | 0.32 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +12.5% | 28.2% | 0.56 | −37.1% | +946% | 0.48 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +12.8% | 22.9% | 0.64 | −36.4% | +429% | 0.30 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +12.4% | 23.8% | 0.61 | −41.0% | +541% | 0.33 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst decline | +19.5% | 34.1% | 0.69 | −33.6% | +652% | -0.03 | — | ||
| Higher return, similar volatilityHigher Sharpe, smaller worst decline | +8.2% | 42.8% | 0.40 | −44.3% | +239% | 0.15 | — | ||
| The whole marketbest 8 shownEvery other stock and fund worth at least $500 million. 2,048 of 3,487 passed at least one test. | |||||||||
| On the frontierHigher return, lower volatilityHigher return in most periods | +51.2% | 33.4% | 1.41 | −79.7% | +1,387% | 0.33 | — | ||
| On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst decline | +3.8% | 0.3% | 13.25 | −0.3% | — | 0.14 | 0.09% | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineSmaller losses in recent crashes | +21.3% | 25.6% | 0.89 | −30.3% | +816% | 0.07 | — | ||
| On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst decline | +17.3% | 18.2% | 0.97 | −40.0% | +352% | 0.08 | — | ||
JAAAJanus Henderson AAA CLO ETF · CLO Bonds | On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst decline | +5.1% | 1.7% | 2.98 | −2.6% | — | 0.19 | 0.20% | |
| Higher return, lower volatilityHigher return in most periods | +44.2% | 36.9% | 1.18 | −71.9% | +1,061% | 0.21 | — | ||
| Higher return, similar volatilityHigher return in most periods | +32.9% | 42.2% | 0.89 | −56.9% | +483% | 0.27 | — | ||
SHMState Street SPDR Nuveen ICE Short Term Municipal Bond ETF · Bonds | Similar return, lower volatilityHigher Sharpe, smaller worst decline | +0.8% | 2.2% | 0.38 | −11.6% | +11.8% | 0.35 | 0.20% | |
What these numbers mean for VEEV
- Annual return
- VEEV lost 0.1% a year over the past 5 years with dividends reinvested, against 12.7% a year for the S&P 500. At that pace, $10,000 became about $9,960. Annual return is the steady yearly rate that would produce the same total result, so investments held over the same span compare fairly. Guide: What is performance and return? →
- Volatility
- VEEV's volatility over the past 5 years was 39.6%, 2.3 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, VEEV's return lands within 39.6% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump. Guide: Understanding and measuring risk (volatility) →
- Sharpe ratio
- VEEV's Sharpe ratio over the past 5 years was 0.19, against 0.79 for the S&P 500, so VEEV earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings. Guide: Balancing reward with risk (Sharpe ratio) →
- Worst decline
- VEEV's worst fall from a peak to a low over the past 10 years was 55.7%, against 33.7% for the S&P 500. Losses and gains are not symmetric: climbing back from a 55.7% fall takes a 126% gain. Guide: Market crash risk and tail risk →
- Correlation
- Over the past 5 years, VEEV's monthly returns had a correlation of 0.38 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against VEEV instead: the lower it is, the more that option would diversify a VEEV holding. Guide: Correlation and diversification →
Show all 1,735 stocks and funds worth at least $500 million that earned more than VEEV with less volatility
Out of 3,633 tested over 5 years. The strongest 100 are listed, best first, with funds that hold the same thing listed once.
| # | Investment | Found in | Annual return | Volatility | Sharpe | Worst decline | 10Y return | Corr. with VEEV | Expense |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Whole market | +51.2% | 33.4% | 1.41 | −79.7% | +1,387% | 0.33 | — | |
| 2 | Whole market | +3.8% | 0.3% | 13.25 | −0.3% | — | 0.14 | 0.09% | |
| 3 | Whole market | +21.3% | 25.6% | 0.89 | −30.3% | +816% | 0.07 | — | |
| 4 | Whole market | +17.3% | 18.2% | 0.97 | −40.0% | +352% | 0.08 | — | |
| 5 | JAAAJanus Henderson AAA CLO ETF · CLO Bonds | Whole market | +5.1% | 1.7% | 2.98 | −2.6% | — | 0.19 | 0.20% |
| 6 | Whole market | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.13 | — | |
| 7 | Whole market | +18.5% | 28.0% | 0.75 | −38.5% | +1,168% | 0.17 | — | |
| 8 | Whole market | +19.0% | 32.0% | 0.71 | −44.6% | +752% | 0.05 | — | |
| 9 | Popular alternative | +40.7% | 32.8% | 1.21 | −34.5% | +1,807% | -0.01 | — | |
| 10 | Whole market | +11.5% | 17.5% | 0.71 | −35.0% | +302% | 0.39 | 0.03% | |
| 11 | Whole market | +12.8% | 16.9% | 0.80 | −34.0% | +324% | 0.38 | 0.03% | |
| 12 | Whole market | +44.2% | 36.9% | 1.18 | −71.9% | +1,061% | 0.21 | — | |
| 13 | Whole market | +20.8% | 22.6% | 0.96 | −25.7% | +508% | 0.08 | — | |
| 14 | Whole market | +13.4% | 17.1% | 0.82 | −29.6% | +274% | 0.15 | — | |
| 15 | Whole market | +17.3% | 24.3% | 0.78 | −43.6% | +537% | 0.28 | — | |
| 16 | Whole market | +26.1% | 23.4% | 1.11 | −45.1% | +603% | 0.15 | — | |
| 17 | Whole market | +12.7% | 17.9% | 0.76 | −27.4% | +196% | 0.07 | — | |
| 18 | DXJWisdomTree Japan Hedged Equity Fund · International Equity | Whole market | +26.6% | 19.1% | 1.34 | −39.1% | +428% | 0.21 | 0.48% |
| 19 | VRIGInvesco Variable Rate Investment Grade ETF · Bonds | Whole market | +4.7% | 1.3% | 3.51 | −13.1% | +40.5% | 0.07 | 0.30% |
| 20 | LVHIFranklin International Low Volatility High Dividend Index ETF · International Equity | Whole market | +17.0% | 11.1% | 1.48 | −32.4% | +194% | 0.11 | 0.40% |
| 21 | CSWCSW Industrials, Inc. · Industrial Products | Whole market | +17.1% | 34.4% | 0.63 | −46.2% | +867% | 0.18 | — |
| 22 | Whole market | +14.7% | 16.8% | 0.91 | −37.0% | +204% | 0.10 | — | |
| 23 | BALTInnovator Defined Wealth Shield ETF · Crypto | Whole market | +6.3% | 3.3% | 1.85 | −4.9% | — | 0.37 | 0.69% |
| 24 | Whole market | +31.1% | 31.9% | 1.01 | −43.4% | +936% | 0.11 | — | |
| 25 | Whole market | +17.4% | 22.9% | 0.82 | −31.4% | +685% | 0.28 | — | |
| 26 | Whole market | +8.2% | 16.4% | 0.57 | −36.0% | +140% | 0.31 | 0.05% | |
| 27 | Whole market | +14.5% | 23.0% | 0.71 | −35.1% | +553% | 0.36 | 0.18% | |
| 28 | Whole market | +21.0% | 23.4% | 0.94 | −42.9% | +242% | 0.07 | — | |
| 29 | Whole market | +16.8% | 26.1% | 0.73 | −42.0% | +374% | 0.23 | — | |
| 30 | Whole market | +38.7% | 25.0% | 1.44 | −38.1% | +586% | 0.06 | — | |
| 31 | Whole market | +17.1% | 20.7% | 0.87 | −26.8% | +226% | 0.06 | — | |
| 32 | Whole market | +33.8% | 32.2% | 1.07 | −37.5% | +965% | 0.22 | — | |
| 33 | Whole market | +12.1% | 13.7% | 0.90 | −36.8% | +235% | 0.29 | 0.03% | |
| 34 | FLRTPacer Aristotle Pacific Floating Rate High Income ETF · Financials | Whole market | +6.0% | 2.3% | 2.55 | −21.0% | +58.0% | 0.31 | 0.60% |
| 35 | Whole market | +19.6% | 24.9% | 0.85 | −24.9% | +266% | 0.08 | — | |
| 36 | Whole market | +22.8% | 24.9% | 0.95 | −30.5% | +200% | 0.15 | — | |
| 37 | Whole market | +19.6% | 28.6% | 0.77 | −48.8% | +521% | 0.28 | — | |
| 38 | Whole market | +9.3% | 16.9% | 0.61 | −35.8% | +153% | 0.30 | 0.03% | |
| 39 | Whole market | +15.8% | 20.0% | 0.84 | −42.0% | +310% | 0.11 | — | |
| 40 | Whole market | +33.6% | 30.6% | 1.10 | −45.7% | +345% | 0.11 | — | |
| 41 | Whole market | +19.9% | 22.3% | 0.93 | −42.5% | +361% | -0.03 | — | |
| 42 | Whole market | +17.7% | 18.9% | 0.96 | −26.4% | +213% | 0.13 | 0.40% | |
| 43 | Whole market | +20.9% | 35.3% | 0.71 | −58.1% | +691% | 0.26 | — | |
| 44 | Whole market | +16.6% | 30.5% | 0.66 | −41.1% | +151% | 0.27 | — | |
| 45 | Whole market | +5.1% | 18.3% | 0.37 | −23.8% | +145% | 0.12 | — | |
| 46 | Whole market | +11.5% | 20.9% | 0.63 | −32.6% | +394% | 0.18 | — | |
| 47 | Whole market | +18.4% | 26.0% | 0.78 | −35.1% | +779% | 0.36 | 0.09% | |
| 48 | Whole market | +33.7% | 29.4% | 1.14 | −47.6% | +474% | 0.05 | — | |
| 49 | Whole market | +16.6% | 31.4% | 0.65 | −44.3% | +398% | 0.11 | — | |
| 50 | Whole market | +13.5% | 29.3% | 0.58 | −49.6% | +446% | 0.21 | — | |
| 51 | Whole market | +15.7% | 20.4% | 0.82 | −42.6% | +248% | -0.04 | — | |
| 52 | Whole market | +39.3% | 37.2% | 1.08 | −45.5% | +2,045% | 0.10 | — | |
| 53 | Whole market | +22.6% | 29.1% | 0.85 | −41.6% | +521% | 0.17 | — | |
| 54 | Whole market | +8.7% | 35.7% | 0.41 | −28.7% | +257% | -0.06 | — | |
| 55 | Whole market | +20.4% | 32.1% | 0.74 | −44.5% | +657% | 0.20 | — | |
| 56 | Whole market | +22.7% | 24.4% | 0.97 | −50.5% | +341% | 0.28 | — | |
| 57 | Whole market | +19.2% | 21.6% | 0.93 | −47.3% | +395% | 0.13 | — | |
| 58 | Whole market | +6.8% | 17.6% | 0.47 | −39.4% | +198% | 0.37 | 0.03% | |
| 59 | Whole market | +14.4% | 29.9% | 0.60 | −37.9% | +755% | 0.23 | — | |
| 60 | Whole market | +10.4% | 14.1% | 0.78 | −31.7% | +258% | 0.36 | 0.04% | |
| 61 | Whole market | +22.4% | 22.3% | 1.02 | −46.3% | +347% | 0.08 | — | |
| 62 | Whole market | +22.7% | 27.7% | 0.88 | −40.5% | +955% | 0.21 | — | |
| 63 | FLOTiShares Floating Rate Bond ETF · Floating Rate Bonds | Whole market | +4.5% | 1.8% | 2.48 | −13.5% | +35.9% | 0.05 | 0.15% |
| 64 | Whole market | +5.0% | 27.0% | 0.32 | −36.8% | +129% | 0.27 | — | |
| 65 | Whole market | +24.2% | 22.8% | 1.07 | −32.4% | +406% | 0.20 | — | |
| 66 | Whole market | +9.7% | 14.3% | 0.72 | −33.4% | +252% | 0.24 | 0.06% | |
| 67 | Whole market | +9.8% | 25.2% | 0.50 | −39.4% | +60.7% | 0.14 | — | |
| 68 | Whole market | +26.3% | 24.9% | 1.07 | −41.6% | +654% | 0.26 | — | |
| 69 | Whole market | +12.9% | 19.9% | 0.71 | −46.9% | +187% | 0.24 | — | |
| 70 | Whole market | +12.2% | 29.0% | 0.54 | −37.5% | +464% | 0.02 | — | |
| 71 | Whole market | +2.7% | 2.9% | 0.94 | −6.3% | +32.7% | 0.14 | 0.03% | |
| 72 | Whole market | +7.1% | 22.9% | 0.42 | −38.7% | +295% | 0.30 | — | |
| 73 | Whole market | +6.2% | 20.6% | 0.40 | −42.0% | +179% | 0.32 | 0.03% | |
| 74 | Whole market | +7.1% | 27.1% | 0.39 | −43.9% | +313% | 0.37 | — | |
| 75 | Whole market | +17.2% | 24.9% | 0.77 | −30.4% | +285% | 0.03 | — | |
| 76 | Whole market | +11.1% | 24.2% | 0.56 | −36.7% | +204% | 0.01 | — | |
| 77 | Whole market | +10.3% | 16.2% | 0.69 | −34.2% | +223% | 0.38 | 0.06% | |
| 78 | Whole market | +11.3% | 18.8% | 0.67 | −38.4% | +170% | -0.13 | — | |
| 79 | Whole market | +16.5% | 23.1% | 0.78 | −48.4% | +808% | 0.33 | — | |
| 80 | Whole market | +6.4% | 26.1% | 0.37 | −44.0% | +253% | 0.16 | — | |
| 81 | Whole market | +6.8% | 19.4% | 0.44 | −38.7% | +122% | 0.26 | 0.09% | |
| 82 | Whole market | +5.2% | 17.5% | 0.38 | −36.4% | +102% | 0.27 | 0.06% | |
| 83 | Whole market | +5.2% | 8.9% | 0.61 | −25.4% | +37.8% | 0.02 | — | |
| 84 | Whole market | +11.2% | 20.8% | 0.62 | −37.4% | +319% | 0.33 | — | |
| 85 | Whole market | +12.0% | 33.2% | 0.51 | −47.8% | +186% | 0.25 | — | |
| 86 | Whole market | +17.4% | 29.1% | 0.70 | −46.4% | +426% | 0.14 | — | |
| 87 | Whole market | +9.1% | 18.9% | 0.56 | −44.1% | +103% | 0.10 | — | |
| 88 | Whole market | +13.9% | 18.5% | 0.80 | −34.0% | +446% | 0.29 | — | |
| 89 | Whole market | +19.9% | 29.0% | 0.77 | −44.0% | +444% | 0.07 | — | |
| 90 | Whole market | +5.2% | 34.6% | 0.32 | −49.9% | +478% | 0.27 | — | |
| 91 | Whole market | +9.0% | 22.9% | 0.49 | −40.8% | +320% | 0.46 | — | |
| 92 | Whole market | +5.5% | 21.5% | 0.36 | −30.1% | +89.8% | 0.16 | — | |
| 93 | PJULInnovator U.S. Equity Power Buffer ETF · Broad Market | Whole market | +10.5% | 8.6% | 1.20 | −18.2% | — | 0.45 | 0.79% |
| 94 | Whole market | +8.2% | 16.1% | 0.57 | −39.0% | +211% | 0.34 | 0.20% | |
| 95 | Whole market | +15.9% | 23.4% | 0.75 | −42.0% | +393% | 0.10 | — | |
| 96 | Whole market | +14.8% | 23.6% | 0.71 | −32.8% | +625% | 0.25 | — | |
| 97 | Whole market | +27.5% | 36.9% | 0.85 | −46.7% | +510% | 0.18 | — | |
| 98 | Whole market | +9.3% | 19.2% | 0.56 | −30.1% | +344% | 0.13 | — | |
| 99 | Whole market | +9.5% | 24.5% | 0.49 | −37.6% | +95.1% | 0.13 | — | |
| 100 | ESLTElbit Systems Ltd. · Aerospace & Defense | Whole market | +39.8% | 34.6% | 1.15 | −35.4% | +765% | 0.01 | — |
VEEV against its popular alternatives
The investments people most often weigh against VEEV, compared period by period and year by year.
How do VEEV's risk and return compare with its alternatives?
This map plots each investment's annual return over the past 5 years against its volatility, the size of its typical price swings. Investments toward the upper left earned more for a smoother ride, and those toward the lower right earned less for a rougher one. The dashed lines cross at VEEV, which divides the map into what did better or worse on each measure.
- Six of the 17 popular alternatives, led by LLY, MRK and SAP, were both more rewarding and calmer than VEEV over the past 5 years, earning a higher annual return with lower volatility.
- Over the past 5 years, VEEV returned -0.1% a year, less than the S&P 500's 12.7%, with higher volatility (39.6% against 17.1%).
Green points earned more than VEEV with less volatility; red points earned less with more. Hover over a point for its figures. Total returns with dividends reinvested, annualized.
All figures
| Investment | Annual return | Volatility |
|---|---|---|
| LLY Eli Lilly and Company | +40.7% | 32.8% |
| MEDP Medpace Holdings, Inc. | +27.1% | 52.0% |
| MRK Merck & Co., Inc. | +16.3% | 24.8% |
| SPY S&P 500State Street SPDR S&P 500 ETF | +12.7% | 17.1% |
| SAP SAP SE | +11.5% | 30.0% |
| ORCL Oracle Corporation | +7.7% | 44.3% |
| HSTM HealthStream, Inc. | +3.9% | 29.4% |
| TMO Thermo Fisher Scientific Inc. | +2.9% | 27.8% |
| NOW ServiceNow, Inc. | +1.9% | 45.5% |
| IQV IQVIA Holdings Inc. | +1.3% | 34.7% |
| VEEV This pageVeeva Systems Inc. | −0.1% | 39.6% |
| CRM Salesforce, Inc. | −3.2% | 39.4% |
| DHR Danaher Corporation | −3.8% | 29.1% |
| CRL Charles River Laboratories International, Inc. | −5.6% | 43.9% |
| WDAY Workday, Inc. | −5.9% | 41.7% |
| DOCS Doximity, Inc. | −14.4% | 65.8% |
| CERT Certara, Inc. | −23.9% | 55.7% |
| PHR Phreesia, Inc. | −28.9% | 60.6% |
| EVH Evolent Health, Inc. | −30.3% | 63.4% |
Has VEEV consistently beaten its popular alternatives?
This section compares VEEV with the investments people most often weigh against it, checking each one over eight periods from one month to ten years. Counting how often an alternative earned more than VEEV helps separate lasting outperformance from a single strong stretch.
- None of the 19 popular alternatives outperformed VEEV in at least 3 of 5 short-term and 2 of 3 long-term timeframes. The closest was MEDP.
- LLY, MRK and MEDP earned more for the risk they took than VEEV (a higher Sharpe ratio) and fell less in their worst decline of the past 10 years.
- LLY outperformed VEEV over all three long-term periods but in only one of the five short-term ones, so VEEV has had the better of it lately.
A green cell means the alternative earned more than VEEV over that period. "Qualified" marks those that did so in at least 3 of 5 short-term periods and 2 of 3 long-term periods.
| Investment | Periods outperformed | Short term | Long term | Risk · 5 years | Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Volatilitylower is calmer | Sharpehigher is better | Worst declinepast 10 years | Expense | Assets | Overlapsame sectors | ||
| VEEV Veeva Systems Inc. (this page) | — | +22.0% | +61.4% | +88.7% | +45.2% | +11.5% | +59.0% | −0.4% | +715% | 39.6% | 0.19 | −55.7% | — | $52B | — |
| MEDP Medical - Diagnostics & ResearchMedpace Holdings, Inc. | 1/5 short3/3 long | −0.3% | +17.9% | +17.8% | +9.0% | +14.3% | +172% | +231% | +1,914% | 52.0% | 0.70 | −42.9% | — | $17B | — |
| LLY Drug Manufacturers - GeneralEli Lilly and Company | 1/5 short3/3 long | +10.2% | +12.1% | +40.0% | +19.4% | +59.7% | +124% | +451% | +1,807% | 32.8% | 1.21 | −34.5% | — | $1.2T | — |
| NOW Software - ApplicationServiceNow, Inc. | 0/5 short2/3 long | +8.6% | +42.8% | +50.0% | +1.4% | −18.5% | +37.8% | +9.8% | +848% | 45.5% | 0.27 | −64.5% | — | $155B | — |
| SAP Software - ApplicationSAP SE | 0/5 short2/3 long | +9.4% | +44.6% | +29.6% | −2.1% | −16.6% | +81.3% | +72.6% | +205% | 30.0% | 0.52 | −52.5% | — | $267B | — |
| CRL Medical - Diagnostics & ResearchCharles River Laboratories International, Inc. | 2/5 short1/3 long | +13.1% | +43.6% | +70.0% | +55.8% | +71.3% | +70.1% | −25.1% | +280% | 43.9% | 0.09 | −78.2% | — | $15B | — |
| HSTM Medical - Healthcare Information ServicesHealthStream, Inc. | 2/5 short1/3 long | +16.1% | +19.3% | +58.7% | +48.8% | +25.8% | +54.1% | +21.2% | +32.0% | 29.4% | 0.28 | −42.7% | — | $1.0B | — |
| TMO Medical - Diagnostics & ResearchThermo Fisher Scientific Inc. | 1/5 short1/3 long | +4.3% | +30.7% | +30.9% | +16.3% | +26.8% | +49.5% | +15.1% | +366% | 27.8% | 0.24 | −40.9% | — | $254B | — |
| IQV Medical - Diagnostics & ResearchIQVIA Holdings Inc. | 1/5 short1/3 long | −0.8% | +31.4% | +51.5% | +18.8% | +26.3% | +45.3% | +6.5% | +260% | 34.7% | 0.21 | −51.5% | — | $44B | — |
| MRK Drug Manufacturers - GeneralMerck & Co., Inc. | 1/5 short1/3 long | −0.8% | +19.9% | +28.3% | +42.2% | +76.8% | +58.3% | +113% | +241% | 24.8% | 0.74 | −43.4% | — | $366B | — |
| ORCL Software - InfrastructureOracle Corporation | 0/5 short1/3 long | −11.4% | +8.4% | −25.6% | −32.1% | −52.1% | +33.3% | +45.1% | +300% | 44.3% | 0.38 | −64.6% | — | $396B | — |
| EVH Medical - Healthcare Information ServicesEvolent Health, Inc. | 1/5 short0/3 long | +32.0% | −17.9% | +66.2% | +25.2% | −37.2% | −81.9% | −83.5% | −79.5% | 63.4% | -0.24 | −94.5% | — | $548M | — |
| DOCS Medical - Healthcare Information ServicesDoximity, Inc. | 1/5 short0/3 long | +24.3% | +53.5% | +36.7% | −23.0% | −51.0% | +51.0% | −54.1% | — | 65.8% | 0.08 | −82.3% | — | $5.9B | — |
| CRM Software - ApplicationSalesforce, Inc. | 0/5 short0/3 long | +2.5% | +39.7% | +30.7% | −3.8% | −3.9% | +21.3% | −14.8% | +240% | 39.4% | 0.12 | −58.7% | — | $200B | — |
| DHR Medical - Diagnostics & ResearchDanaher Corporation | 0/5 short0/3 long | +4.0% | +11.6% | +15.0% | −2.2% | +8.3% | +10.8% | −17.6% | +232% | 29.1% | 0.01 | −43.8% | — | $157B | — |
| WDAY Software - ApplicationWorkday, Inc. | 0/5 short0/3 long | +6.3% | +38.6% | +59.4% | −0.9% | −15.4% | −3.4% | −26.4% | +132% | 41.7% | 0.06 | −63.4% | — | $49B | — |
| CERT Medical - Healthcare Information ServicesCertara, Inc. | 0/5 short0/3 long | +14.8% | +41.0% | +58.1% | +12.0% | −20.5% | −27.6% | −74.4% | — | 55.7% | -0.21 | −90.1% | — | $1.5B | — |
| PHR Medical - Healthcare Information ServicesPhreesia, Inc. | 0/5 short0/3 long | +20.1% | +12.8% | +27.8% | −26.1% | −47.5% | −20.2% | −81.8% | — | 60.6% | -0.26 | −90.0% | — | $748M | — |
| TEM Medical - Healthcare Information ServicesTempus AI, Inc. | 0/5 short0/3 long | −14.5% | +37.9% | +17.6% | +7.0% | −27.8% | — | — | — | — | — | −59.8% | — | $12B | — |
| WAY Medical - Healthcare Information ServicesWaystar Holding Corp. | 0/5 short0/3 long | +12.1% | +30.4% | +7.9% | −8.2% | −22.1% | — | — | — | — | — | −61.8% | — | $5.5B | — |
How did VEEV do year by year?
This table shows each investment's total return in every full calendar year since 2014, along with where VEEV ranked among its popular alternatives each year. Annual results reveal how consistently each one kept pace with VEEV and how far its good and bad years diverged, detail that multiyear averages tend to smooth over.
Note: VEEV began trading on October 16, 2013, so the table starts with 2014, its first full calendar year, and cannot show how it fared during the dot-com bust, the 2008 financial crisis or two other sell-offs.
- VEEV finished ahead of the S&P 500 in six of its 12 full calendar years, and behind it in each of the last five.
- Among its popular alternatives, LLY came out ahead of VEEV most often, in seven of the 12 years both traded.
- Ranked against its popular alternatives each year, VEEV finished in the top quarter in four of 12 years and in the bottom quarter in two. In 2025, it ranked 9 of 20.
Newest year first. Green marks a year in which the fund came out ahead of VEEV; gray means the two finished within a fraction of a point. The rank row places VEEV among the alternatives that traded the full year; dark green is the top quarter and red the bottom quarter.
| Investment | Years ahead of VEEV | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VEEV This pageVeeva Systems Inc. | — | +6.2% | +9.2% | +19.3% | −36.8% | −6.2% | +93.5% | +57.5% | +61.6% | +35.8% | +41.1% | +9.2% | −17.7% |
| Rank among alternatives | Top quarter in 4 of 12 | 9 of 20 | 8 of 18 | 8 of 18 | 13 of 18 | 15 of 17 | 3 of 16 | 3 of 15 | 2 of 15 | 5 of 15 | 2 of 14 | 9 of 13 | 12 of 13 |
| SPY S&P 500State Street SPDR S&P 500 ETF | 6 of 12 | +17.7% | +24.9% | +26.2% | −18.2% | +28.7% | +18.3% | +31.2% | −4.6% | +21.7% | +12.0% | +1.2% | +13.5% |
| MEDP Medpace Holdings, Inc. | 4 of 9 | +69.1% | +8.4% | +44.3% | −2.4% | +56.4% | +65.6% | +58.8% | +46.0% | +0.5% | — | — | — |
| LLY Eli Lilly and Company | 7 of 12 | +40.3% | +33.3% | +60.9% | +34.3% | +66.1% | +31.0% | +16.2% | +40.5% | +17.8% | −10.4% | +25.4% | +39.8% |
| NOW ServiceNow, Inc. | 6 of 12 | −27.8% | +50.0% | +82.0% | −40.2% | +17.9% | +95.0% | +58.6% | +36.5% | +75.4% | −14.1% | +27.6% | +21.2% |
| SAP SAP SE | 5 of 12 | −0.4% | +61.3% | +52.3% | −24.2% | +9.2% | −1.3% | +36.4% | −10.0% | +31.7% | +11.1% | +15.3% | −18.6% |
| CRL Charles River Laboratories International, Inc. | 5 of 12 | +8.1% | −21.9% | +8.5% | −42.2% | +50.8% | +63.6% | +35.0% | +3.4% | +43.6% | −5.2% | +26.3% | +20.0% |
| HSTM HealthStream, Inc. | 4 of 12 | −27.1% | +18.1% | +9.2% | −5.8% | +20.7% | −19.7% | +12.6% | +8.7% | −7.5% | +13.9% | −25.4% | −9.7% |
| TMO Thermo Fisher Scientific Inc. | 5 of 12 | +11.8% | −1.7% | −3.4% | −17.3% | +43.5% | +43.7% | +45.6% | +18.2% | +35.0% | −0.1% | +13.8% | +13.1% |
| IQV IQVIA Holdings Inc. | 5 of 12 | +14.7% | −15.1% | +12.9% | −27.4% | +57.5% | +16.0% | +33.0% | +18.7% | +28.7% | +10.8% | +16.6% | +27.0% |
| MRK Merck & Co., Inc. | 4 of 12 | +9.8% | −6.3% | +1.0% | +49.4% | +1.8% | −7.2% | +22.3% | +40.0% | −1.5% | +15.0% | −3.9% | +16.9% |
| ORCL Oracle Corporation | 6 of 12 | +18.1% | +60.0% | +30.9% | −4.7% | +36.9% | +24.3% | +19.4% | −3.0% | +24.9% | +6.9% | −17.6% | +19.0% |
| EVH Evolent Health, Inc. | 2 of 10 | −64.4% | −65.9% | +17.6% | +1.5% | +72.6% | +77.1% | −54.6% | +62.2% | −16.9% | +22.2% | — | — |
| DOCS Doximity, Inc. | 2 of 4 | −17.1% | +90.4% | −16.4% | −33.1% | — | — | — | — | — | — | — | — |
| CRM Salesforce, Inc. | 6 of 12 | −20.2% | +27.8% | +98.5% | −47.8% | +14.2% | +36.8% | +18.7% | +34.0% | +49.3% | −12.7% | +32.2% | +7.5% |
| DHR Danaher Corporation | 4 of 12 | +0.4% | −0.4% | −1.2% | −19.0% | +48.6% | +45.4% | +49.5% | +11.8% | +20.0% | +73.2% | +9.3% | +11.6% |
| WDAY Workday, Inc. | 4 of 12 | −16.8% | −6.5% | +65.0% | −38.8% | +14.0% | +45.7% | +3.0% | +57.0% | +53.9% | −17.1% | −2.4% | −1.9% |
| CERT Certara, Inc. | 0 of 5 | −17.3% | −39.5% | +9.5% | −43.5% | −15.7% | — | — | — | — | — | — | — |
| PHR Phreesia, Inc. | 2 of 6 | −32.8% | +8.7% | −28.5% | −22.3% | −23.2% | +104% | — | — | — | — | — | — |
| TEM Tempus AI, Inc. | 1 of 1 | +74.9% | — | — | — | — | — | — | — | — | — | — | — |
| WAY Waystar Holding Corp. | 0 of 1 | −10.8% | — | — | — | — | — | — | — | — | — | — | — |
Risk and diversification
How VEEV has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.
What were VEEV's worst declines?
A drawdown is the decline from a peak to the lowest point before a new high. This section presents VEEV's five deepest drawdowns since it began trading in 2013, alongside the S&P 500's return over the same dates, and how long each took to recover. Together, these figures show how much an investor could have lost and how long it took to get back to even.
Note: VEEV began trading on October 16, 2013, so this list cannot include the dot-com bust, the 2008 financial crisis or two other sell-offs. The crash tests on this page show how older funds and the S&P 500 fared through those years.
- In all five of VEEV's worst declines, the S&P 500 held up better over the same dates.
- Not every decline was the market's doing: VEEV fell 61.4% from October 2013 to May 2014, while the S&P 500 rose 8.8%.
- The slowest recovery came after VEEV fell 61.4% from October 2013 to May 2014; it did not regain that peak until November 2016, two years later.
Green means VEEV fell less than the S&P 500 over the same dates. Based on daily closing prices with dividends reinvested.
| During | VEEV fell | S&P 500, same dates | Peak | Low | Time to the low | Back at the peak | Time to recover |
|---|---|---|---|---|---|---|---|
| No named crash | −61.4% | +8.8% | Oct 2013 | May 2014 | 7 months | Nov 2016 | 2.5 years |
| 2022 bear market | −55.7% | −17.6% | Aug 2021 | Oct 2022 | 14 months | Not yet | — |
| Covid crash | −31.1% | −19.1% | Jul 2019 | Mar 2020 | 8 months | Apr 2020 | 1 month |
| Late-2018 sell-off | −26.5% | −18.9% | Sep 2018 | Dec 2018 | 3 months | Jan 2019 | 1 month |
| No named crash | −24.2% | −2.7% | Feb 2021 | Mar 2021 | 1 month | Jun 2021 | 3 months |
How did VEEV do in stock market crashes?
This section measures how far VEEV, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000. A smaller decline means an investment held up better, and comparing results across crashes shows whether that resilience was consistent or a one-off.
Note: VEEV began trading on October 16, 2013, so its row reads "Not yet trading" for the dot-com bust, the 2008 financial crisis or two other sell-offs. The older alternatives and the S&P 500 show how those crashes played out.
- VEEV fell further than the S&P 500 in five of the six crashes it has traded through. The clearest case was the 2015 China and oil sell-off, when VEEV fell 28.9% and the S&P 500 fell 12.8%.
- Among its popular alternatives, LLY held up best, falling less than VEEV in all six crashes they both traded through.
- VEEV began trading after the 2008 financial crisis, but nine of its popular alternatives lived through it. The mildest fall among them was ORCL's 41.1%, against 55.2% for the S&P 500.
Newest crash first. Each figure is the fund's deepest fall within the crash window; green means a smaller fall than VEEV.
| Investment | Held up better | 2023 regional bank crisisMar 2023 | 2022 bear marketJan 2022 | Covid crashFeb 2020 | Late-2018 sell-offSep 2018 | February 2018 volatility shockFeb 2018 | 2015 China and oil sell-offAug 2015 | 2011 euro debt crisisJul 2011 | 2010 flash crashMay 2010 | 2008 financial crisisOct 2007 | Dot-com bustMar 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VEEV This pageVeeva Systems Inc. | — | −4.6% | −40.0% | −26.7% | −26.5% | −9.5% | −28.9% | Not yet trading | Not yet trading | Not yet trading | Not yet trading |
| SPY S&P 500State Street SPDR S&P 500 ETF | 5 of 6 | −3.4% | −24.5% | −33.7% | −19.3% | −6.5% | −12.8% | −17.9% | −1.5% | −55.2% | −47.5% |
| MEDP Medpace Holdings, Inc. | 2 of 5 | −11.9% | −36.4% | −39.5% | −26.1% | −2.1% | — | — | — | — | — |
| LLY Eli Lilly and Company | 6 of 6 | −0.6% | −11.7% | −16.9% | −10.2% | −8.6% | −19.6% | −10.9% | 0.0% | −50.0% | −54.3% |
| NOW ServiceNow, Inc. | 2 of 6 | −7.2% | −39.9% | −28.8% | −20.6% | −8.5% | −47.6% | — | — | — | — |
| SAP SAP SE | 4 of 6 | −2.0% | −41.9% | −32.6% | −25.0% | −6.9% | −13.3% | −25.0% | −1.4% | −49.6% | −87.9% |
| CRL Charles River Laboratories International, Inc. | 3 of 6 | −7.7% | −49.3% | −44.5% | −23.4% | −4.6% | −19.1% | −33.3% | −1.8% | −69.8% | — |
| HSTM HealthStream, Inc. | 5 of 6 | −3.9% | −27.0% | −23.6% | −25.3% | −5.6% | −31.8% | −26.0% | −1.4% | −54.5% | — |
| TMO Thermo Fisher Scientific Inc. | 6 of 6 | −2.4% | −19.8% | −24.8% | −17.2% | −8.7% | −14.7% | −24.4% | −3.6% | −53.9% | −41.8% |
| IQV IQVIA Holdings Inc. | 3 of 6 | −6.8% | −35.9% | −48.9% | −19.2% | −5.3% | −28.7% | — | — | — | — |
| MRK Merck & Co., Inc. | 6 of 6 | −2.4% | −10.8% | −19.3% | −9.7% | −6.6% | −18.2% | −17.4% | −2.3% | −63.3% | −57.5% |
| ORCL Oracle Corporation | 4 of 6 | −5.0% | −31.0% | −28.3% | −17.2% | −6.6% | −16.1% | −23.9% | −2.1% | −41.1% | −84.2% |
| EVH Evolent Health, Inc. | 2 of 6 | −12.0% | −23.5% | −69.1% | −38.3% | −3.9% | −56.7% | — | — | — | — |
| DOCS Doximity, Inc. | 0 of 2 | −11.5% | −56.5% | — | — | — | — | — | — | — | — |
| CRM Salesforce, Inc. | 2 of 6 | −5.3% | −42.7% | −35.7% | −24.8% | −6.1% | −34.2% | −26.9% | −4.2% | −70.5% | — |
| DHR Danaher Corporation | 5 of 6 | −3.2% | −22.8% | −25.9% | −13.4% | −9.8% | −14.0% | −21.8% | −0.6% | −45.7% | −33.7% |
| WDAY Workday, Inc. | 3 of 6 | −2.8% | −47.0% | −42.4% | −17.3% | −5.8% | −42.3% | — | — | — | — |
| CERT Certara, Inc. | 0 of 2 | −8.2% | −56.9% | — | — | — | — | — | — | — | — |
| PHR Phreesia, Inc. | 0 of 3 | −10.5% | −66.0% | −51.4% | — | — | — | — | — | — | — |
How closely does VEEV move with the S&P 500?
Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell. An investment that captures more of the gains than the losses has compounded ahead of the market over time. This section compares VEEV with its popular alternatives on both measures, and on beta (how strongly each has moved with the market), over the past 10 years.
- Over the past 10 years, VEEV captured 113% of the S&P 500's gains in rising months and 89% of its losses in falling months, with a beta of 0.87. Its share of the market's gains was larger than its share of the losses.
- LLY took just 6% of the S&P 500's losses, against 89% for VEEV, while still keeping 101% of its gains.
- Four of the 14 popular alternatives had a higher capture ratio (upside capture divided by downside capture) than VEEV's 1.26, led by LLY, NOW and MEDP.
Monthly total returns over the past 10 years, measured against SPY. 100% capture or a beta of 1.00 means moving in line with the S&P 500. Green marks a better figure than VEEV's: more upside, less downside or a higher capture ratio. Sorted by capture ratio.
| Investment | Upside capture | Downside capture | Capture ratio | Beta |
|---|---|---|---|---|
| VEEV This pageVeeva Systems Inc. | 113% | 89% | 1.26 | 0.87 |
| LLY Eli Lilly and Company | 101% | 6% | 15.73 | 0.37 |
| NOW ServiceNow, Inc. | 114% | 79% | 1.45 | 0.97 |
| MEDP Medpace Holdings, Inc. | 168% | 118% | 1.42 | 1.24 |
| MRK Merck & Co., Inc. | 64% | 46% | 1.39 | 0.30 |
| DHR Danaher Corporation | 84% | 84% | 1.01 | 0.75 |
| TMO Thermo Fisher Scientific Inc. | 104% | 104% | 1.00 | 0.81 |
| ORCL Oracle Corporation | 131% | 159% | 0.82 | 1.30 |
| CRM Salesforce, Inc. | 115% | 143% | 0.80 | 1.16 |
| CRL Charles River Laboratories International, Inc. | 135% | 175% | 0.77 | 1.30 |
| IQV IQVIA Holdings Inc. | 128% | 167% | 0.77 | 1.31 |
| SAP SAP SE | 112% | 152% | 0.74 | 1.10 |
| WDAY Workday, Inc. | 96% | 139% | 0.70 | 1.19 |
| HSTM HealthStream, Inc. | 33% | 57% | 0.58 | 0.40 |
| EVH Evolent Health, Inc. | 23% | 176% | 0.13 | 1.60 |
What diversifies VEEV?
Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions). This section lists large ETFs and stocks whose returns have had a low correlation with VEEV's. Because such investments tend not to fall at the same time, pairing VEEV with them can reduce a portfolio's overall swings.
- Moving a fifth of the money in VEEV into LVHI would have cut the portfolio's volatility by 19% over the past 5 years and raised its annual return (-0.2% for VEEV alone, +4.1% for the mix).
- MCK made money in three of the three calendar years in which VEEV lost money.
- Among large ETFs, LVHI, DXJ and EMLP have moved largely independently of VEEV over the past 5 years, with correlations of 0.21 or lower, and each still earned a positive 5-year return.
Only ETFs with at least $1.0B in assets and stocks worth at least $10B, with a correlation below 0.5 over the past 5 years and a positive return, are included, ranked by Sharpe ratio; funds that hold the same thing are shown once. The year columns are the years in which VEEV lost money. The last two columns show a portfolio that is 80% VEEV and 20% the other investment, rebalanced monthly.
ETFs
| Investment | Correlation | 5Y return | Sharpe | 2022 | 2021 | 2014 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc. (this page) | 1.00 | −0.4% | 0.19 | −36.8% | −6.2% | −17.7% | 37.7% | −0.2% |
| LVHI InternationalFranklin International Low Volatility High Dividend Index ETF | 0.11 | +119% | 1.48 | +3.8% | +17.8% | — | 30.4% | +4.1% |
| DXJ InternationalWisdomTree Japan Hedged Equity Fund | 0.21 | +225% | 1.34 | +6.0% | +18.0% | +8.1% | 30.8% | +5.8% |
| EMLP Broad MarketFirst Trust North American Energy Infrastructure Fund | 0.15 | +101% | 1.04 | +10.4% | +23.1% | +23.8% | 30.7% | +3.9% |
| HDV Dividend & IncomeiShares Core High Dividend ETF | 0.20 | +83.3% | 1.00 | +7.1% | +19.6% | +12.6% | 30.8% | +3.2% |
| SMH TechnologyVanEck Semiconductor ETF | 0.18 | +323% | 0.97 | −33.5% | +42.1% | +30.2% | 32.1% | +8.2% |
| DBEF InternationalXtrackers MSCI EAFE Hedged Equity ETF | 0.30 | +85.0% | 0.96 | −5.1% | +19.6% | +3.4% | 30.9% | +3.4% |
| GLD CommoditiesSPDR Gold Shares | 0.13 | +126% | 0.96 | −0.8% | −4.2% | −2.2% | 30.8% | +4.5% |
| SPMO Broad MarketInvesco S&P 500 Momentum ETF | 0.29 | +136% | 0.93 | −10.4% | +22.7% | — | 31.6% | +4.9% |
Stocks
| Investment | Correlation | 5Y return | Sharpe | 2022 | 2021 | 2014 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc. (this page) | 1.00 | −0.4% | 0.19 | −36.8% | −6.2% | −17.7% | 37.7% | −0.2% |
| CAH Medical - DistributionCardinal Health, Inc. | 0.13 | +479% | 1.55 | +54.1% | −0.4% | +23.0% | 31.3% | +8.0% |
| CLS Hardware, Equipment & PartsCelestica Inc. | 0.09 | +3,143% | 1.47 | +1.3% | +37.9% | +12.9% | 33.3% | +19.8% |
| FIX Engineering & ConstructionComfort Systems USA, Inc. | 0.10 | +1,636% | 1.46 | +17.0% | +89.0% | −10.4% | 32.3% | +16.1% |
| MCK Medical - DistributionMcKesson Corporation | 0.06 | +413% | 1.44 | +51.8% | +44.2% | +29.3% | 30.9% | +7.5% |
| MPC Oil & Gas Refining & MarketingMarathon Petroleum Corporation | 0.33 | +690% | 1.41 | +86.6% | +61.0% | +0.4% | 32.9% | +9.5% |
Common questions
What was VEEV's worst drawdown?
VEEV's deepest decline since it began trading in 2013 was 61.4%, from October 2013 to May 2014. It took about two years from the low to climb back to its old high. Because VEEV launched in October 2013, that record does not include the dot-com bust, the 2008 financial crisis or two other sell-offs.
What were VEEV's best and worst years?
Over 12 full calendar years, VEEV's best year was 2020, when it returned 93.5%. Its worst was 2022, with a return of -36.8%.
Is there a better investment than VEEV?
Among VEEV's popular alternatives, LLY, MRK and SAP earned more than VEEV with less volatility over the past 5 years. LLY returned 40.7% a year at 32.8% volatility, against a loss of 0.1% a year at 39.6%. Looking beyond its popular alternatives, MSFT (software) and V (payment processing) earned more than VEEV with less volatility over the past 5 years. MSFT returned 12.5% a year at 28.2% volatility, against a loss of 0.1% a year at 39.6%.
Is VEEV more volatile than the S&P 500?
Yes. VEEV's volatility over the past 5 years was 39.6%, 2.3 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, VEEV's return lands within 39.6% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.
What is VEEV's Sharpe ratio?
VEEV's Sharpe ratio over the past 5 years was 0.19, against 0.79 for the S&P 500, so VEEV earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.
How correlated is VEEV with the S&P 500?
Over the past 5 years, VEEV's monthly returns had a correlation of 0.38 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against VEEV instead: the lower it is, the more that option would diversify a VEEV holding.
What are the best alternatives to VEEV?
None of the 19 popular alternatives we compared outperformed VEEV in at least 3 of 5 short-term and 2 of 3 long-term timeframes, which says more about VEEV's strength than about its alternatives.
Did VEEV outperform the S&P 500?
VEEV finished ahead of the S&P 500 (SPY) in six of 12 full calendar years. In 2025, it returned +6.2%, against +17.7% for the index.
How did VEEV do in stock market crashes?
VEEV fell less than the S&P 500 (SPY) in one of the six major crashes it has traded through, and further in five. The clearest case was the 2015 China and oil sell-off, when VEEV fell 28.9% and the S&P 500 fell 12.8%.
What diversifies VEEV?
These had a low correlation with VEEV over the past 5 years and still earned a positive 5-year return: among large ETFs, LVHI (correlation 0.11), DXJ (correlation 0.21) and EMLP (correlation 0.15); among large stocks, CAH (correlation 0.13), CLS (correlation 0.09) and FIX (correlation 0.10). A correlation near zero means the two have moved largely independently.
How we measure
- Short-term periods are 1M, 3M, 6M, YTD, 1Y; long-term periods are 3Y, 5Y, 10Y. An investment outperformed in a period when its total return, with dividends reinvested, was higher than VEEV's. Returns within 0.5 points or 3% of VEEV's, whichever is larger, count as a tie.
- "Qualified" means outperforming in at least 3 of 5 short-term periods and 2 of 3 long-term periods. "All-weather" means outperforming in every long-term period and all but one short-term period.
- Popular alternatives are the funds and stocks most often compared with this one. We include only those that trade today, are not leveraged or inverse, and hold at least $200 million.
- Volatility is the annualized standard deviation of daily returns over 5 years, a measure of how much the price typically swings in a year. The Sharpe ratio is the return above cash for each unit of that volatility.
- A decline, or drawdown, runs from a peak to the lowest close before the next high. The worst decline ever uses all the price history we have; comparisons between funds use the past 10 years so that younger funds are judged on the same stretch.
- Sector overlap is the share of assets two funds hold in the same sectors. Correlation and the mixed-portfolio figures use monthly returns.
- Upside and downside capture follow Morningstar's definition: the compound monthly return in the months the S&P 500 rose (or fell), divided by the S&P 500's compound return in those months. Beta measures how strongly monthly returns have moved with the S&P 500. All three use the same window for every investment.
- Figures are computed from daily adjusted prices and update after each trading day. Past performance does not predict future results.
More research
Popular alternatives to VEEV
LLYEli Lilly and Company
NOWServiceNow
SAPSAP
TMOThermo Fisher Scientific
IQVIQVIA
MRKMerck & Co., Inc.
ORCLOracle
CRMSalesforce
DHRDanaher
WDAYWorkday